Sanofi | SNY - Devedores Comerciais

Preço das Ações
46.04
Mudança Diária
0.08 0.17%
Mensal
-1.56%
Anual
-16.22%
Q2 Previsão
45.74




Devedores Comerciais Alterar Data
AbbVie USD 12.59B 180M 2025-12
Amgen USD 9.57B 1.08B 2025-12
AstraZeneca USD 17.88B 1.17B 2026-03
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Canopy Growth CAD 140.42M 113.56M 2025-12
Corcept Therapeutics USD 59.79M 9.84M 2025-12
Drreddys Laboratories INR 1.41B 11.6M 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Galapagos EUR 199.75M 122.08M 2025-12
Genmab DKK 1.17B 119M 2025-12
GlaxoSmithKline GBP 7.94B 178M 2026-03
Glaxosmithkline GBP 10.45B 707.81M 2025-12
J&J USD 21.33B 3.72B 2025-12
Merck USD 12.12B 596M 2025-09
Novartis USD 12.29B 3.3B 2025-12
Novartis USD 12.29B 3.3B 2025-12
Pacira USD 124.07M 8.8M 2025-12
Perrigo USD 612.8M 31.6M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Phibro Animal Health USD 215.87M 2.02M 2025-12
Prestige Brands USD 190.46M 8.54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 482M 85M 2026-03
Sanofi EUR 397M 186.13M 2025-12
Supernus Pharmaceuticals USD 187.8M 16.55M 2025-12
UCB EUR 1.97B 54M 2025-12
Zoetis USD 1.59B 49M 2025-12